Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study

Documenti analoghi

• Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial
  di: Henry C. Mandeville, et al.
  Pubblicazione: (2024)
• Reply to “Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?”
  di: Henry C. Mandeville, et al.
  Pubblicazione: (2025)
• Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram
  di: Gian Luca De Salvo, et al.
  Pubblicazione: (2024)
• Impact of Centres With Different Patient Volume on Diagnostic Process, Therapeutic Strategy and Outcome in Patients With Localised Rhabdomyosarcoma: A Report From the European paediatric Soft tissue sarcoma Study Group (E p SSG)
  di: Maria Carmen Affinita, et al.
  Pubblicazione: (2026)
• Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion‐Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS‐2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry
  di: Amadeus T. Heinz, et al.
  Pubblicazione: (2024)